Partnership program advances Alveo’s be.well™ platform accessibility and adoption in new global markets and industry sectors; New partnerships establishedALAMEDA, Calif.--(BUSINESS ...
Cambridge-based Cyted, an early cancer diagnostics company, announced on Wednesday, May 17, that it has secured £13.4M (approximately €15.4M) in ...
Delta Diagnostics aims to transform biosensing technology by making label-free, multiplexed biosensors and devices available to everyone.
Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April ...
Aiosyn aims to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients globally.
Osler Diagnostics is a diagnostics company whose purpose is to enable anyone, anywhere, to access, understand, and act on their ...
miDiagnostics is active in the development of a new generation diagnostic platform for point-of-care testing based on nano-fluidic semiconductor technology.
Spiden uses optical and AI-based technology to analyse blood, urine, and other body fluids for the first time non-destructively and ...
Based out of Zurich, Bloom Diagnostics develop devices that help users to keep a track, maintain, and improve their health. ...
Artificial Intelligence and machine learning have seeped into almost every aspect of human lives, including healthcare, and life sciences. Perhaps ...
